Skip to search.
 FTSE 100 Down 0.29%

Becton, Dickinson and Company (BDX)

-NYSE
179.73 Up 3.29(1.86%) 21:02
|After Hours: : 179.73 0.00 (0.00%) 21:17
Prev Close:176.44
Open:177.02
Bid:180.33 x 200
Ask:180.34 x 300
1y Target Est:183.04
Beta:0.975248
Earnings Date:2 Nov - 7 Nov (Est.)
Day's Range:177.02 - 180.57
52wk Range:129.50 - 181.76
Volume:1,087,347
Avg Vol (3m):788,447
Market Cap:38.27b
P/E (ttm):34.30
EPS (ttm):5.24
Div & Yield:2.64 (1.48%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for BDX at this time.

Comparison

Symbol% ChgMkt Cap
BDXUp 1.86%38.27b
BAXUp 1.45%25.89b
ABTUp 2.05%62.17b

Key Statistics

Forward P/E (1 yr):19.00
P/S (ttm):3.05
Ex-Dividend Date:07-Sep-16

Analysts

Annual EPS Est (Sep-16) :8.56
Quarterly EPS Est (Sep-16) :2.09
Mean Recommendation*:2.1
PEG Ratio (5 yr expected):1.54

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Becton, Dickinson and Company develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company’s BD Medical segment offers syringes and pen needles for diabetes; needles, syringes, and intravenous cat... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback